{
    "organizations": [],
    "uuid": "b56b9e2101a5212ffa92a358296c18b4d332512c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-revive-therapeutics-announces-excl/brief-revive-therapeutics-announces-exclusive-license-agreement-with-wisconsin-alumni-research-foundation-for-cannabinoid-delivery-technology-idUSFWN1S70NQ",
    "ord_in_thread": 0,
    "title": "BRIEF-Revive Therapeutics Announces Exclusive License Agreement With Wisconsin Alumni Research Foundation For Cannabinoid Delivery Technology",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 30 (Reuters) - Revive Therapeutics Ltd:\n* REVIVE THERAPEUTICS ANNOUNCES EXCLUSIVE LICENSE AGREEMENT WITH WISCONSIN ALUMNI RESEARCH FOUNDATION FOR CANNABINOID DELIVERY TECHNOLOGY Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-30T19:06:00.000+03:00",
    "crawled": "2018-05-01T20:18:24.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "revive",
        "therapeutic",
        "ltd",
        "revive",
        "therapeutic",
        "announces",
        "exclusive",
        "license",
        "agreement",
        "wisconsin",
        "alumnus",
        "research",
        "foundation",
        "cannabinoid",
        "delivery",
        "technology",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}